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DIFFERENTIAL EXPRESSION OF TGF-BETA ISOFORMS
IN HUMAN OSTEOARTHRITIC CARTILAGE
A. Gonzalez, M. Pombo-Suarez, M. Calaza, J.J. Gomez-Reino
Hospital Clinico Universitario de Santiago, Santiago de
Compostela, Spain
Purpose: TGF-beta is known to play a pivotal role in the repar-
ative process of osteoarthritic cartilage. We aimed to test if the
wide use of “TGF-beta” to refer to the three isoforms TGF-beta1,
TGF-beta2 and TGF-beta3, without distinction between them,
can be assumed without risk in OA research. As a ﬁrst step,
we have explored if they are similarly expressed in human OA
cartilage.
Methods: A total of 24 patients that were undergoing total hip
replacement were recruited. 12 of them had hip OA and 12 had
hip fracture but without clinical, radiologic or macroscopic OA.
Gene expression of the 3 TGF-beta isoforms, collagen type II and
aggrecan was analyzed by RT-qPCR using RNA obtained from
fresh femoral head cartilage. Immunohistochemistry was used
to study the expression and distribution of TGF-beta isoforms in
different stages of OA: normal, slightly and strongly altered hip
cartilage.
Results: Expression of the three TGF-beta isoforms was signiﬁ-
cantly increased in OA cartilage. The increase was more marked
for the TGF-beta3 isoform than for TGF-beta1 and TGF-beta2.
TGF-beta3 levels were independent from the levels of the other
two isoforms suggesting differential regulation. The mRNA levels
of TGF-beta1 and TGF-beta2 were strongly correlated in OA
cartilage (Spearman’s r=0.83, p=0.002) but not in control carti-
lage. Levels of TGF-beta2 were lower than those of TGF-beta1
and TGF-beta3. Immunohistochemistry was in agreement with
the qPCR results and showed that the three isoforms were over-
expressed in the superﬁcial layer of OA cartilage and near the
lesions.
Conclusions: Assuming that TGF-beta isoforms act indistinctly
in OA is unwarranted. TGF-beta3 showed differential regulation in
relation with TGF-beta1 and TGF-beta2. This might be important
for OA given recent evidence suggesting that TGF-beta isoforms
may have differing biological activities
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Purpose: Osteoarthritis is deﬁned by loss of cartilage cells
and extra cellular matrix including the major compound collagen
II. Methylation is an epigenetic event and to date intensively
studied in carcinogenesis. It was shown that certain genes can
be silenced by this molecular genetic mechanism. There is not
much known about this regulatory mechanism in cartilage.
We hypothesize that methylation plays a key role in collagen II
loss in human cartilage cells.
Methods: We collected eight probes of macroscopic normal hu-
man cartilage and arthritic areas before undergoing total knee
joint replacement under sterile conditions from osteoarthritis pa-
tients (5 female, 3 male). Patient’s average age was 70 years
(min 54, max 83). After digestion the cells were spread out and
half of them were treated with 10 uM of demethylation agent
5-AZA-deoxy-cytidine over a period of six days. After harvesting
the cells, RNA was extracted using the Trizol method and cDNA
was transcribed. Gene expression for Collagen II was performed
with the Taqman Realtime PCR Assay.
Results: There was a signiﬁcant decrease of collagen II expres-
sion in the normal human cartilage cell cultures after treatment
with 5-Aza-deoxy-cytidine compared to the untreated ones. In-
terestingly there was no difference in the gene expression of
collagen II in the arthritic cell cultures after treatment with 5-Aza-
deoxy-cytidine.
Conclusions: Further investigations have to be done but these
results lead use to the thought, that methylation may play an
important role in the development of Osteoarthritis and collagen
II loss and may be a new target of therapeutic strategies in the
future.
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IN VITRO EFFECTS OF DIACERHEIN ON IL-1β
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Purpose: Osteoarthritis (OA) is a progressive joint disease which
represents a combination of several disorders leading to cartilage
degradation. The degenerative process may be initiated with the
loss of proteoglycans from the ECM followed by disruption of
collagenous ﬁbrillar network leading to cell apoptosis/necrosis
and deterioration of the functional tissue. Cytokines produced
by the synovium and chondrocytes, especially interleukin IL-
1, play a signiﬁcant role in the degradation of cartilage. The
production of nitric oxide (NO) stimulated by proinﬂammatory
cytokines, is involved in cartilage catabolism and should therefore
be considered a potential target for therapeutic interventions.
Drug and non-drug treatments are used to relieve pain and/or
swelling in OA. Diacerein is a slow-acting drug that may slow
down the breakdown of cartilage and relieve pain and swelling. It
has been proposed that diacerein acts as a symptom-modifying
and disease-structure modifying drug. The aim of this work was
to evaluate the effect of diacerhein on IL-1β stimulated articular
chondrocytes from human OA cartilage.
Methods: Intracellular iNOS and COX-2 distribution and synthe-
sis were detected by confocal microscopy and NO production by
using the Griess method. Moreover, NO production in hypoxia
conditions (5% O2) was also analysed.
Results: Results showed that in the absence of stimulation,
a weak iNOS and COX-2 expression was detected but there
was an increase (intensity and number of spots) when IL-1β was
added. DAR decrease intracellular iNOS expression in stimulated
chondrocytes but no effect was observed in COX-2 expression.
Similar results where obtained when quantiﬁcation of intracellular
iNOS was achieved by ﬂow cytometry. In parallel, NO production
increase after IL-1β stimulation of cells and this effect was de-
creased by DAR under normoxia and hypoxia. These results are
in concordance with our precedent study (de Isla et al, Biorhe-
ology 2006,43:595-601) which shows an inhibitory effect of DAR
on IL-1β production.
Conclusions: Our results suggest an inhibitory effect of DAR
at therapeutic concentrations on NO and iNOS production by
articular chondrocytes cultured in vitro under normoxia, but also
under hypoxic conditions.
